Affiliation:
1. Nanfang Hospital, Southern Medical University
2. First People's Hospital of Foshan
Abstract
Abstract
Objective: For patients on maintenance hemodialysis, hyperkalemia has now been
lowered from 5.5 mmol/L to 5.0 mmol/L. We undertook this study in order to clarify the incidence of hyperkalemia under this new criterion, to determine the associated risk factors, and to provide guidance for the prevention of hyperkalemia.
Methods: Data from all hemodialysis centers of Foshan City were included in a crosssectional survey, the overall incidence of hyperkalemia was determined and the risk factors were analyzed.
Results: Our study comprised 2582 patients from 34 dialysis centers. 107 patients (4.14%) with serum potassium levels at or below 3.5 mmol/L, 1473(57.05%) with serum potassium levels between 3.5 and 5.0 mmol/L, 494 (19.13%) with serum potassium levels between 5.0 and 5.5 mmol/L, and 508 (19.67%) with serum potassium levels above 5.5 mmol/L. The Incidence of hyperkalemia was significantly greater under the new criterion than the old criterion (38.81% vs 19.67%, P <0.001).
We divided the patients into non-hyperkalemia and hyperkalemia groups by the new criterion. Patients in the hyperkalemia group were younger, higher body-mass indices (BMIs), higher systolic and diastolic blood pressures, higher serum creatinine, higher serum blood urea nitrogen (BUN), lower pre-dialysis carbon dioxide combining power (CO2CP), and less residual urine volume(RUV), higher proportion of using angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Through multiple logistic regression analysis, we found that systolic blood pressure, RUV, ACEI/ARB usage, pre-dialysis CO2CP, and pre-dialysis BUN were independent risk factors for hyperkalemia.
Conclusion: In the Foshan area, the incidence of hyperkalemia in patients on maintenance hemodialysis is very high. Under the new criterion, the diagnosis rate of hyperkalemia would be significantly increased. Moreover, high systolic blood pressure,decreased RUV, decreased pre-dialysis CO2CP, increased pre-dialysis BUN, and the use of ACEIs/ARBs were found to be independent risk factors for hyperkalemia.
Publisher
Research Square Platform LLC
Reference15 articles.
1. Hyperkalemia: pathophysiology, risk factors and consequences;Hunter RW;Nephrol Dial Transplant,2019
2. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis;Kovesdy CP;Eur Heart J,2018
3. Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients;Iwagami M;J Clin Med,2023
4. of hyperkalemia in maintenance hemodialysis patients in China. Guideline on the management of hyperkalemia in maintenance hemodialysi patients in China[J];Expert group of guideline on the management;Chin J Blood Purif,2022
5. Xiangmei Chen.”Blood Purification Standard Operating Procedure”. (2021 Edition) [M].People's Health Publishing House, 2021: 271.